Senior Research Fellow
PhD
Tim Barnett is a NHMRC Hot North Fellow at the Telethon Kids Institute, Perth, and has worked in the area of Streptococcus pyogenes (Group A Streptococcus, GAS) research since his PhD (2000). He pursued postdoctoral studies in two of the leading GAS research laboratories at Emory University (June Scott) and the University of Queensland (Mark Walker), and made a number of significant contributions to this field. These include the first characterisation of the enzymes (sortases) that covalently attach proteins to the GAS cell wall, demonstration that growth phase changes in gene expression are mediated by changes in mRNA stability, and the description of a novel mechanism that GAS uses to evade the innate immune pathway that protects host cells from intracellular bacteria (autophagy). In 2017, he joined Telethon Kids Institute to investigate disease-causing mechanisms, antibiotic resistance and adverse immunological outcomes associated with GAS skin and throat infections.
-
Projects
-
Publications
August 2021
Streptolysins are the primary inflammasome activators in macrophages during Streptococcus pyogenes infection
Group A Streptococcus (GAS) is a Gram-positive bacterial pathogen that causes an array of infectious diseases in humans. Accumulating clinical evidence suggests that proinflammatory interleukin (IL)-1beta signaling plays an important role in GAS disease progression.
Published research Rheumatic Heart Disease Infectious Diseases Group A Streptococcal & Rheumatic Heart Disease Invasive Streptococcus A DiseaseSeptember 2021Searching for a technology-driven acute rheumatic fever test: the START study protocol
The absence of a diagnostic test for acute rheumatic fever (ARF) is a major impediment in managing this serious childhood condition. ARF is an autoimmune condition triggered by infection with group A Streptococcus.
Published research Rheumatic Heart Disease Systems Immunology Group A Streptococcal & Rheumatic Heart Disease Computational Biology Systems VaccinologyOctober 2020Prophage exotoxins enhance colonization fitness in epidemic scarlet fever-causing Streptococcus pyogenes
The re-emergence of scarlet fever poses a new global public health threat. The capacity of North-East Asian serotype M12 (emm12) Streptococcus pyogenes (group A Streptococcus, GAS) to cause scarlet fever has been linked epidemiologically to the presence of novel prophages
Published research Infectious Diseases Allergy & Infectious DiseasesJanuary 2020Genetic Manipulation of Group A Streptococcus-Gene Deletion by Allelic Replacement
An optimized, rapid method for creating markerless isogenic mutations that combines Gibson assembly cloning with a new temperature-sensitive plasmid, pLZts
Published research Infectious Diseases Skin HealthJanuary 2019The fall and rise of Group A Streptococcus diseases
We overview the changing epidemiology of Group A Streptococcus infections and the genetic alterations that accompany the emergence of Group A Streptococcus strains
Published research Group A Streptococcal & Rheumatic Heart Disease Skin HealthFebruary 2019Group A Streptococcus co-ordinates manganese import and iron efflux in response to hydrogen peroxide stress
Here, we demonstrate that group A Streptococcus (GAS) utilises Mn(II) import via MtsABC during conditions of hydrogen peroxide stress
Published research Skin HealthSeptember 2019SToP (See, Treat, Prevent) skin sores and scabies trial: study protocol for a cluster randomised, stepped-wedge trial for skin disease control in remote Western Australia
Skin infection burden in remote Aboriginal communities can be reduced by the See, Treat, Prevent (SToP skin sores and scabies) trial
Published research Skin Infections Group A Streptococcal & Rheumatic Heart Disease Skin HealthMay 2018Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP
Our results suggest that intracellular infection with the pathogenic GAS M1T1 clone induces a strong pro-inflammatory response in primary tonsil epithelial cells
Published research Group A Streptococcal & Rheumatic Heart DiseaseFebruary 2018Group A streptococcal pharyngitis: Immune responses involved in bacterial clearance and GAS-associated immunopathologies
Innate and adaptive host immune responses are fundamental for defense against streptococcal pharyngitis and are central to the clinical manifestation of disease.
Published research Group A Streptococcal & Rheumatic Heart Disease -
Education and Qualifications
-
Awards/Honours
-
Active Collaborations